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n the lactating breast, ERBB4 localizes to the nuclei of
secretory epithelium while regulating activities of the
signal transducer and activator of transcription (STAT)
5A transcription factor essential for milk-gene expression.
We have identiﬁed an intrinsic ERBB4 NLS (residues
676–684) within the ERBB4 intracellular domain (4ICD)
that is essential for nuclear accumulation of 4ICD. To de-
termine the functional signiﬁcance of 4ICD nuclear trans-
location in a physiologically relevant system, we have
demonstrated that cotransfection of ERBB4 and STAT5A
in a human breast cancer cell line stimulates 
 
 
 
-casein
promoter activity. Signiﬁcantly, nuclear localization of
I
 
STAT5A and subsequent stimulation of the 
 
 
 
-casein pro-
moter requires nuclear translocation of 4ICD. Moreover,
4ICD and STAT5A colocalize within nuclei of heregulin
 
 
 
1 (HRG)-stimulated cells and both proteins bind to the
endogenous 
 
 
 
-casein promoter in T47D breast cancer
cells. Together, our results establish a novel molecular
mechanism of transmembrane receptor signal transduction
involving nuclear cotranslocation of the receptor intracellu-
lar domain and associated transcription factor. Subsequent
binding of the two proteins at transcription factor target
promoters results in activation of gene expression.
 
Introduction
 
The ERBB family of receptor tyrosine kinases, namely the
EGF receptor (EGFR), ERBB2/HER2/Neu, ERBB3, and
ERBB4, regulate cellular proliferation, differentiation, and pro-
grammed cell death in a growth factor–dependent manner. Sev-
eral recent reports have described nuclear translocation of
EGFR, ERBB3, and ERBB4 (Lin et al., 2001; Ni et al., 2001;
Lee et al., 2002; Offterdinger et al., 2002). ERBB4 is the only
member of the ERBB family that encodes both putative nuclear
localization and nuclear export signals providing a mechanism
for regulating nuclear accumulation of the ERBB4 protein. In
addition, recent reports have detailed a unique proteolytic
cleavage mechanism leading to nuclear translocation of the
ERBB4 intracellular domain (4ICD). Essential for ERBB4 nu-
clear translocation is the sequential proteolytic cleavage of
ERBB4 at the cell membrane to release 4ICD. These process-
ing events are catalyzed by TNF
 
 
 
-converting enzyme (TACE)
and presenilin-dependent 
 
 
 
-secretase activity (Rio et al., 2000;
Ni et al., 2001; Lee et al., 2002).
ERBB4 has multiple functions during embryogenesis
(Gassmann et al., 1995) and ERBB4 expression has recently
been shown to be essential during breast development and
lactation (Long et al., 2003; Tidcombe et al., 2003). Criti-
cal ERBB4 activities in the breast are mediated, in part,
through ERBB4-induced activation of the signal transducer and
activator of transcription (STAT) family member, STAT5A.
ERBB4-mediated activation of STAT5A in the pregnant and
lactating breast results in STAT5A transactivation of milk
genes with 
 
 
 
-interferon activation sites (GAS) within their pro-
moters, including 
 
 
 
-casein and whey acidic protein (Long et
al., 2003). Interestingly, both ERBB4 and STAT5A localize
to the nuclei of secretory epithelium during lactation and
STAT5A nuclear localization requires ERBB4 expression
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(Long et al., 2003). Furthermore, experiments demonstrating
coimmunoprecipitation of ERBB4 and STAT5A (Jones et al.,
1999) raise the possibility that these two proteins exist in a
functionally important nuclear complex.
Despite detailed biochemical descriptions of ERBB4 pro-
teolytic cleavage events and several reports of nuclear ERBB
receptors, the molecular mechanisms and physiological rele-
vance of ERBB nuclear translocation remain to be determined.
Our previous demonstration of nuclear localization of ERBB4
within mammary secretory epithelium coincident with the es-
sential contribution of ERBB4 to STAT5A regulated milk-
gene expression (Long et al., 2003) led us to hypothesize that
4ICD nuclear translocation modulates transactivation of STAT5A
target genes. Here, we support our hypothesis through the iden-
tification and inactivation of an intrinsic ERBB4 NLS. We fur-
ther demonstrate that nuclear 4ICD uses a novel signal trans-
duction mechanism to potentiate the expression of STAT5A
target genes.
 
Results
 
Identification of an ERBB4 basic residue 
stretch sufficient to enhance nuclear 
accumulation of EGFP
 
As an experimental approach toward the identification of an in-
trinsic ERBB4 NLS, we tested the ability of three independent
ERBB4 basic residue stretches positioned within 4ICD (Fig. 1
A; Srinivasan et al., 2000) to enhance nuclear translocation of
EGFP. When transiently transfected into HEK 293T cells the
EGFP (Fig. 1 B) vector control and amino-terminal EGFP fu-
sions of NLS2 (Fig. 1 D) and NLS3 (Fig. 1 E) displayed identi-
cal patterns of diffuse cytoplasmic localization accompanied
by basal levels of nuclear accumulation. An NLS1-EGFP fu-
sion (Fig. 1 C) on the other hand exhibited distinct nuclear ac-
cumulations within subnuclear structures resembling nucleoli.
Although these results do not exclude a role for NLS2 and
NLS3 in nuclear translocation, consistent with our results, a
putative juxtamembrane EGFR NLS, with basic residue clus-
ters similar to the ERBB4 NLS1, was shown to mediate nuclear
translocation of 
 
 
 
-galactosidase (Lin et al., 2001).
Having identified a minimal ERBB4 sequence that en-
hances EGFP nuclear accumulation, we next attempted to iden-
tify regions essential for NLS1-mediated EGFP nuclear ac-
cumulation by incorporating several independent mutations
within the three basic residue clusters of NLS1 (Fig. 1 F; basic
residues indicated in red). Nuclear accumulation of muNLS1-
EGFP (681–682; Fig. 1 H) and muNLS1-EGFP (687–688; Fig.
1 J) indicates that NLS1 can sustain residue substitutions at
these sites. Substitutions at residues 676–678 (Fig. 1 G) or
681–684 (Fig. 1 I), however, returned nuclear accumulation of
NLS1 fused to EGFP to basal levels. These results suggest that
ERBB4 residues 676–684 constitute a functional NLS.
 
NLS1 mediates nuclear translocation of 
the 4ICD
 
We created NLS1 inactivating base substitutions at residues
681–684 (Fig. 1 F) in two versions of the wild-type ERBB4
protein, one fused at the carboxyl terminus with EGFP
(ERBB4muNLS-EGFP) and the other harboring tandem car-
boxyl-terminal Flag epitope tags (ERBB4muNLS). We con-
firmed that ERBB4 fused to EGFP retained the ability to asso-
ciate with and activate STAT5A fused at the amino terminus
to 
 
Discosoma
 
 red fluorescent protein (dsRed; Red-STAT5A;
Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200403155/DC1). Furthermore, we show that altering
ERBB4 residues 681–684 does not impact ERBB4 growth
factor stimulation or proteolytic processing to release 4ICD
(Fig. S2, available at http://www/jcb.org/cgi/content/full/
jcb.200403155/DC1).
We next examined the contribution of NLS1 to ERBB4
nuclear translocation by deconvolution microscopy of MCF-
7B human breast cancer cells (Burow et al., 2001) transiently
transfected with ERBB4-EGFP or ERBB4muNLS-EGFP. In
untreated cells, the majority of ERBB4-EGFP was localized to
the cellular membrane and perinuclear region (Fig. 2, A–C).
Treatment of transfected cells with the ERBB4 ligand heregu-
lin 
 
 
 
1 (HRG) dramatically enhanced both perinuclear and nu-
clear accumulation of ERBB4/4ICD (Fig. 2, G–I and Y).
ERBB4 also encodes three putative nuclear export signals har-
bored within 4ICD (Ni et al., 2001). Therefore, we treated
transfected cells with the inhibitor of chromatin region mainte-
nance 1/exportin 1 nuclear export protein, leptomycin B (LMB;
Kudo et al., 1999). LMB treatment resulted in nuclear retention
of 
 
 
 
90% of basal-activated ERBB4/4ICD (Fig. 2, M–O and Y)
and 
 
 
 
80% of HRG-activated ERBB4/4ICD (Fig. 2, S–V and Y).
Strikingly, mutation of NLS1 completely abolished ERBB4/
4ICD nuclear translocation under each condition tested (Fig. 2
Y), indicating that NLS1 of ERBB4 is a functionally active
intrinsic NLS mediating nuclear translocation of 4ICD. In
another experimental system, NIH 3T3 cells were stably
transfected to express physiological levels of ERBB4-Flag
or ERBB4muNLS-Flag. Despite equivalent levels of HRG-
induced tyrosine phosphorylation, nuclear accumulation of
Figure 1. Identification of a minimal ERBB4 sequence that enhances EGFP
nuclear accumulation. (A) ERBB4 residues representing putative NLSs
fused to the amino terminus of EGFP. (B–E) Localization by deconvolution
microscopy of indicated NLS-EGFP constructs 48 h after transfection of
HEK 293T cells. (F) Basic residues (red) altered in NLS1-EGFP fusions. (G–J)
Localization by deconvolution microscopy of indicated NLS1-EGFP mu-
tants 48 h after transfection of HEK 293T cells. 
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ERBB4/4ICD was only observed in cells expressing ERBB4-
Flag (Fig. S3, available at http://www.jcb.org/cgi/content/full/
jcb.200403155/DC1).
The contribution of NLS1 to 4ICD nuclear localization
was confirmed by Western blot analysis of nuclear extracts
isolated from transiently transfected and HRG-stimulated
MCF-7B cells. Despite high levels of ERBB4 and 4ICD pro-
tein within the membrane/cytosolic fractions from ERBB4-
Flag and ERBB4muNLS-Flag–transfected cells (Fig. 3, lanes
2 and 3), 4ICD was not detected within the nuclei of
mock-stimulated cells (Fig. 3, lanes 5 and 6). As predicted,
4ICD was detected in nuclear extracts from HRG-stimulated
ERBB4-Flag transfected cells (Fig. 3, lane 11), however,
HRG failed to drive nuclear translocation of 4ICD in
ERBB4muNLS–transfected cells (Fig. 3, lane 12). Some
membrane ERBB4 contamination was observed in nuclear ex-
tracts of HRG-treated cells (Fig. 3, lanes 11 and 12). Together,
our cellular microscopy and biochemical data strongly impli-
cate NLS1 as a functional ERBB4 NLS mediating nuclear
translocation of 4ICD.
 
ERBB4 nuclear translocation regulates 
STAT5A transactivation
 
We next determined the function of nuclear 4ICD using a phys-
iologically relevant experimental system. Our recent in vivo
data indicates that ERBB4 activation of STAT5A in the mam-
mary gland regulates lactational expression of the essential
milk-genes 
 
 
 
-casein
 
 and 
 
whey acidic protein
 
 (Jones et al.,
2003; Long et al., 2003). As an extension of these observations
we next determined if ERBB4 stimulates STAT5A transactiva-
tion of a bovine 
 
 
 
-casein promoter positioned upstream of the
luciferase reporter gene.
Relative to the empty vector control, independent expres-
sion of STAT5A or ERBB4 resulted in insignificant levels of
 
 
 
-casein promoter activity (Fig. 4). Coexpression of ERBB4 and
STAT5A, however, resulted in a 
 
 
 
40-fold increase in 
 
 
 
-casein
reporter activity (Fig. 4) demonstrating for the first time that an
ERBB receptor directly regulates STAT5A transactivation. As
predicted activation of the 
 
 
 
-casein promoter was abolished
when STAT5A was cotransfected with an ERBB4 mutant lack-
ing intrinsic kinase activity (ERBB4KD; Sartor et al., 2001) or
Figure 2. ERBB4 nuclear translocation re-
quires an intact NLS1. MCF-7B cells were
transfected with ERBB4-EGFP (A–C, G–I, M–O,
and S–U) or ERBB4muNLS-EGFP (D–F, J–L, P–R,
and V–X) harboring base substitutions
(K681E, K682I, K683M, R684G) within
NLS1. Immediately before fixation in 4% PFA
at 48 h after transfection cells were treated by
(A–F) mock stimulation, (G–L) stimulation with
50 ng/ml of HRG for 30 min at RT (HRG),
(M–R) incubation with 10 ng/ml of LMB for
12 h (LMB), or (S–X) a combination of HRG
and LMB treatments (HRG/LMB). After fixa-
tion, nuclei were stained with Hoechst dye
and observed by deconvolution microscopy.
(Y) The mean percentage of EGFP fluores-
cence in the cytoplasmic or nuclear compart-
ments for each treatment was determined by
analyzing EGFP intensities from 10 transfected
cells. Bar, 8  m. 
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when ERBB4 was cotransfected with a STAT5A protein har-
boring a mutation that ablates SH2 activity (STAT5AR618V)
and thus disrupting the interaction between ERBB4 and
STAT5A (Fig. 4; Jones et al., 1999). Strikingly, when STAT5A
was cotransfected with ERBB4 harboring an inactive NLS1
(ERBB4muNLS), a significant and dramatic decrease in
STAT5A transactivation was observed (Fig. 4). This ablation of
STAT5A transactivation was observed despite equivalent levels
of ERBB4 and ERBB4muNLS-induced STAT5A phosphoryla-
tion at the regulatory STAT5A Y694 (Fig. 4, top). Together,
these results clearly indicate that nuclear translocation of 4ICD
regulates STAT5A transactivation of the 
 
 
 
-casein milk-gene
promoter, implicating a physiologically important role for
4ICD nuclear translocation during milk-gene expression.
 
Mutation of the ERBB4 NLS prevents 
STAT5A nuclear accumulation
 
In the mouse, both ERBB4 and activated STAT5A localize to the
nuclei of mammary secretory epithelium while providing essential
functions during lactation (Long et al., 2003; Tidcombe et al.,
2003). Interestingly, STAT5A fails to encode essential basic resi-
dues constituting a STAT NLS originally identified in STAT1
(Melen et al., 2001; Meyer et al., 2002). Therefore, we examined
the possibility that ERBB4 regulates STAT5A transactivation by
augmenting STAT5A nuclear translocation. We cotransfected
MCF-7B cells with ERBB4-EGFP and Red-STAT5A, determined
the subcellular localization of each protein by deconvolution mi-
croscopy, and quantitated the levels of ERBB4-EGFP and Red-
STAT5A colocalization using a pixel correlation algorithm.
Deconvolution microscopy revealed ERBB4 accumula-
tion at the cell membrane of mock-treated cells with a high level
of cytoplasmic STAT5A colocalization, probably representing
STAT5A associated with constitutively activated ERBB4 pro-
tein (Fig. 5 A, top, and Fig. 5 B). When cotransfected cells were
stimulated with HRG, pronounced nuclear accumulation and
dramatic nuclear colocalization of 4ICD and STAT5A was ob-
served (Fig. 5 A, bottom, and Fig. 5 B). The punctate pattern of
4ICD/STAT5A nuclear colocalization resembles sub-nuclear
structures referred to as nuclear speckles. The exact function of
nuclear speckles remains controversial but appear to be sites of
splicing machinery assembly associated with highly active tran-
scription (Lamond and Spector, 2003).
Although significant levels of cytoplasmic and perinu-
clear ERBB4/4ICD and STAT5A colocalization was ob-
served in cells cotransfected with STAT5A and ERBB4-
muNLS (Fig. 5 C, top, and Fig. 5 D), both proteins were
excluded from the nucleus, even under conditions of HRG
stimulation (Fig. 5 C, bottom, and Fig. 5 D). Together, these
results imply that nuclear translocation and subsequent nu-
clear colocalization of 4ICD and STAT5A requires an in-
tact ERBB4 NLS, implicating 4ICD as a nuclear chaperone
for STAT5A.
Figure 3. Nuclear accumulation of the 4ICD requires an intact NLS1.
Transfected MCF-7B cells were mock stimulated or treated with 50 ng/ml
of HRG for 30 min. Cell lysates were prepared and separated into mem-
brane/cytosolic (Mem/Cyto) and nuclear fractions. The lysates were ana-
lyzed by PAGE and Western blot using an antibody directed against the
carboxyl-terminal Flag epitope tags of ERBB4 and ERBB4muNLS. The 80-kD
ERBB4 cleavage product, 4ICD, was detected in Mem/Cyto fractions of
ERBB4 (lanes 2 and 8) and ERBB4muNLS (lanes 3 and 9) transfected cells
but only in the nuclear fractions of HRG-stimulated ERBB4 transfected cells
(lane 11). A high molecular mass nonspecific band was detected in Mem/
Cyto extracts prepared from vector control transfected cells (lanes 1 and
7) and nuclear extracts prepared from HRG-stimulated ERBB4 and
ERBB4muNLS transfected cells (lanes 11 and 12). Each experiment de-
tected a variable but low level of full-length ERBB4 contamination in nuclear
extracts prepared from HRG-stimulated cells (lanes 11 and 12).
Figure 4. ERBB4 nuclear translocation modulates STAT5A stimulation of
the  -casein promoter. MCF-7B cells were cotransfected with the bovine
 -casein promoter fused to luciferase and plasmids expressing the indi-
cated cDNAs. Cell lysates were prepared at 2 d after transfection and
luciferase activity was determined using standard methods. Results are
reported as fold increase in luciferase activity relative to  -casein pro-
moter luciferase cotransfected with empty vector controls. ERBB4/STAT5A
stimulation of the  -casein promoter was significantly greater than each of
the other treatments (* indicates P   0.05). ERBB4muNLS/STAT5A stimu-
lation of the  -casein promoter was significantly greater than the ERBB4
kinase-dead (ERBB4KD/STAT5A) and STAT5A SH2 domain mutant
(ERBB4-Flag/STAT5AR618V) negative controls (** indicates P   0.05).
Each treatment was preformed in duplicate and the entire experiment was
repeated three times. STAT5A was immunoprecipitated from lysates pre-
pared for luciferase assay and analyzed by Western blot for STAT5A ex-
pression and activation by phosphorylation at the regulatory Y694 (top). 
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ERBB4/4ICD associates with STAT5A in 
the cytosol and at the 
 
 
 
-casein promoter
 
Perinuclear colocalization of ERBB4/4ICD and STAT5A (Fig.
5) suggests that the two proteins exist in a cytosolic complex
before nuclear translocation. We have reported previously an
interaction between the ERBB4 holoreceptor and STAT5A
(Jones et al., 1999). To determine if 4ICD also interacts with
STAT5A we cotransfected COS-7 cells with ERBB4-Flag or
ERBB4muNLS-Flag and STAT5A and probed STAT5A im-
munoprecipitates for ERBB4/4ICD using a Flag antibody.
Consistent with our previous results, the ERBB4 holoreceptor
was detected in STAT5A immunoprecipitates from lysates of
cells transfected with ERBB4-Flag/STAT5A and ERBB4mu-
NLS-Flag/STAT5A (Fig. 6 A, lanes 5, 6, 11, and 12). Signifi-
cantly, 4ICD was detected in the same samples indicating that
STAT5A and 4ICD exist in a cytosolic complex. An interac-
tion between cytosolic 4ICD and STAT5A supports the con-
tention that perinuclear 4ICD chaperones associated STAT5A
across the nuclear membrane. Due to the high levels of ERBB4
constitutive activation in transient transfected cells (Fig. S2)
HRG treatment had little impact on the association between
ERBB4/4ICD and STAT5A.
Nuclear colocalization of 4ICD and STAT5A raised the
possibility that the two proteins exist in a functionally impor-
tant complex bound to the promoters of STAT5A target genes.
To determine if 4ICD and STAT5A associate at STAT5A tar-
get promoters in vivo we performed a chromatin immunopre-
cipitation (ChIP) assay in T47D breast cancer cells and exam-
ined HRG-stimulated association of 4ICD and STAT5A at
distal and proximal regions of the endogenous 
 
 
 
-casein
 
 pro-
moter (Fig. 6 B). In mock-stimulated T47D cells antibodies
against ERBB4 and STAT5A precipitated a small but detect-
Figure 5. Activated ERBB4 mediates nuclear
translocation of coexpressed STAT5A. MCF-7B
cells were cotransfected with (A and B) Red-
STAT5A and ERBB4-EGFP or (C and D) Red-
STAT5A and ERBB4muNLS-EGFP. Immediately
before fixation in 4% PFA at 48 h after transfec-
tion, cells were mock stimulated (Mock) or stimu-
lated with 50 ng/ml of HRG for 30 min at RT
(HRG). After fixation, cells were stained with
Hoechst dye and observed by deconvolution mi-
croscopy. Cytoplasmic and nuclear colocaliza-
tion of ERBB4 (green) and STAT5A (red) of 10 co-
transfected cells in the merged image (Merge
w/Hoechst) was measured using a pixel correla-
tion algorithm (B and D). Bar, 5  m. 
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able amount of the proximal (
 
 
 
294/
 
 
 
1) and distal (
 
 
 
4719/
 
 
 
4276) 
 
 
 
-casein promoter regions (Fig. 6 C, lanes 3 and 4),
harboring a single and three STAT5A binding GAS sites, re-
spectively (Fig. 6 B; Winklehner-Jennewein et al., 1998). As
predicted, stimulation of T47D cells with prolactin (Prl) re-
sulted in increased STAT5A but not 4ICD binding to the
 
 
 
-casein promoter (Fig. 6 C, lanes 7 and 8). Significantly, a
dramatic increase in both STAT5A and 4ICD binding to the
 
 
 
-casein promoter was observed after HRG stimulation of
T47D cells (Fig. 6 C, lanes 11 and 12). As predicted, Prl and
HRG failed to stimulate binding of STAT5A or 4ICD to a re-
gion of the 
 
 
 
-casein promoter lacking GAS sites (
 
 
 
923/
 
 
 
590).
Together, our results imply that 4ICD modulates STAT5A
transactivation by first functioning as a STAT5A nuclear chap-
erone, then 4ICD may function as a transcriptional cofactor at
STAT5A target promoters. Indeed, we (unpublished data) and
others (Ni et al., 2001) have observed transactivation activity
harbored within 4ICD.
 
Discussion
 
We have identified a novel signal transduction pathway in
which the ERBB4 transmembrane receptor regulates gene
expression by functioning as a nuclear chaperone for the
STAT5A transcription factor. After nuclear cotranslocation of
the 4ICD and STAT5A both proteins associated in a complex
at the 
 
 
 
-casein
 
 promoter. Based on our observations, we pro-
pose a unique mechanism for ERBB4 regulation of STAT5A-
stimulated gene activation (Fig. 7). Recent evidence indicates
that HRG stimulation and subsequent proteolytic processing of
ERBB4 at the cell surface results in release of 4ICD from the
cell membrane (Rio et al., 2000; Ni et al., 2001; Lee et al.,
2002). Here, we propose that 4ICD first accumulates in the
perinuclear region. Then in a process requiring an intact NLS
(residues 676–684) a 4ICD perinuclear/nuclear equilibrium is
established. An efficient nuclear export mechanism, which is
inhibited by LMB, maintains the equilibrium toward perinu-
clear 4ICD. When coexpressed, activated ERBB4 associates
with the STAT5A transcription factor in a STAT5A SH2-
dependent manner (Jones et al., 1999). STAT5A remains asso-
ciated with 4ICD and the two proteins colocalize in the perinu-
clear region. Nuclear translocation and subsequent nuclear
colocalization of both proteins requires an intact ERBB4 NLS.
Interestingly, we also observe pronounced nuclear retention
of 4ICD when coexpressed with STAT5A, indicating that
STAT5A impairs 4ICD nuclear export, thereby dramatically
shifting the 4ICD perinuclear/nuclear equilibrium in favor of
nuclear accumulation. Finally, activation of the ERBB4/STAT5A
signal transduction pathway and subsequent nuclear cotranslo-
cation of 4ICD and STAT5A results in binding of the two pro-
teins at STAT5A target gene promoters culminating in a robust
stimulation of STAT5A target genes possibly potentiated by
transactivation activity harbored within 4ICD. Together, our
results suggest a novel molecular mechanism to explain our in
vivo observations demonstrating ERBB4/STAT5A cooperative
activation of essential milk-genes during lactation (Jones et al.,
2003; Long et al., 2003).
Of the four ERBB family members nuclear localization
of three receptors, namely EGFR (Lin et al., 2001), ERBB3
(Offterdinger et al., 2002), and ERBB4 (Ni et al., 2001), has
been described recently. The lack of a confirmed ERBB NLS,
however, has hampered progress toward identification of the
functional implications of ERBB nuclear translocation. Never-
theless, ligand activation of EGFR results in association of nu-
clear EGFR with the cyclin D1 promoter and EGF stimulation
of the cyclin D1 promoter fused to luciferase requires EGFR
expression. Interestingly, EGFR harbors independent transacti-
Figure 6. The 4ICD and STAT5A associate in vivo and bind to the endog-
enous  -casein promoter. (A) 4ICD is associated with STAT5A. COS-7
cells were transfected with the indicated expression plasmids and at 2 d
after transfection cells were mock stimulated or stimulated with 50 ng/ml
of HRG for 30 min at RT. ERBB4 and STAT5A immunoprecipitates were
prepared from cell lysates, resolved by PAGE, and probed for ERBB4
and/or STAT5A by Western blot. White lines indicate that intervening
lanes have been spliced out. (B) Schematic of  -casein gene indicating
positions of primers for semi-quantitative PCR of distal ( 4719/ 4276)
and proximal ( 294/ 1) upstream regulatory regions and a promoter
region lacking STAT5A GAS binding sites ( 923/ 590). Gray boxes in-
dicate positions of STAT5A GAS binding sites (Winklehner-Jennewein et
al., 1998). (C) Semi-quantitative PCR amplification of DNA bound to
ERBB4 and STAT5A isolated by ChIP assay. T47D breast cancer cells
were mock stimulated, stimulated with 5  g/ml of ovine Prl, or stimulated
with 50 ng/ml of HRG for 30 min at RT. PFA cross-linked chromatin was
immunoprecipitated using control rabbit IgG or antibodies directed
against ERBB4 and STAT5A and subjected to 35 cycles of PCR. Input
chromatin was prepared from cross-linked and cleared cell lysates using
standard DNA precipitation procedures and amplified by PCR as above.
PCR amplified samples were resolved on a 2% agarose gel and stained
with ethidium bromide. 
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vation activity raising the possibility of direct gene activation
by nuclear EGFR (Lin et al., 2001). Similarly, we (unpublished
data) and others (Ni et al., 2003) have identified transactivation
activity harbored within 4ICD. Association of 4ICD with
STAT5A at STAT5A target promoters may potentiate STAT5A
stimulation of gene expression. Our identification of a func-
tional ERBB4 NLS may also be relevant for EGFR nuclear
translocation. The ERBB4 NLS and the putative EGFR NLS
(Lin et al., 2001) share basic residue stretches positioned im-
mediately downstream of the transmembrane domain. These
observations imply that ERBB4 and EGFR nuclear activities
are functionally and mechanistically similar.
Nuclear translocation of ERBB4 does however require
proteolytic processing at the cell membrane to release the 4ICD
nuclear protein, whereas both EGFR and ERBB3, appear to be
transported to the nucleus as holoreceptors (Lin et al., 2001;
Offterdinger et al., 2002). Inhibitors of presenilin-dependent
 
 
 
-secretase activity suggest that this ERBB4 processing event
is essential for 4ICD nuclear accumulation (Ni et al., 2001; Lee
et al., 2002). Interestingly, we have identified a transmembrane
valine (V673) residue critical for 
 
 
 
-secretase–mediated ERBB4
cleavage and mutation of this residue (V673I) abolishes 4ICD
nuclear translocation (unpublished data). A similarly posi-
tioned valine within the Notch1 transmembrane is essential for
 
 
 
-secretase processing of this receptor and nuclear transloca-
tion of the Notch1 intracellular domain (Schroeter et al., 1998).
EGFR and ERBB3, on the other hand, encode a leucine (L642)
and a phenylalanine (F644), respectively, at the same trans-
membrane position and therefore lack a canonical 
 
 
 
-secretase
cleavage site. This difference in proteolytic processing at the
cell membrane may explain why EGFR and ERBB3 are trans-
ported to the nucleus as holoreceptors whereas 4ICD is the pre-
dominant ERBB4 nuclear protein.
STAT5A-mediated nuclear retention of 4ICD raises two
unresolved questions, specifically, what is the mechanism of
4ICD nuclear retention and what, if any, is the physiological
consequence of retaining 4ICD in the nucleus. Although the ex-
act mechanism of STAT5A regulated nuclear retention of 4ICD
remains unclear, retention of STAT proteins is mediated by an
intrinsic DNA binding domain (Herrington et al., 1999; Meyer et
al., 2003). STAT5A DNA binding activity may similarly inhibit
nuclear export of 4ICD associated with STAT5A at STAT5A
target gene promoters. In support of this contention, we observe
binding of STAT5A and 4ICD at endogenous 
 
 
 
-casein promoter
regions harboring STAT5A DNA binding sites. Alternatively,
mechanisms regulating ERBB4 nuclear export may be masked
or sterically hindered through an association with STAT5A.
Our data clearly indicate that ERBB4 can indirectly regu-
late gene expression by functioning as a nuclear chaperone for
STAT5A. Additionally, association of 4ICD and STAT5A at
STAT5A target promoters suggests that 4ICD may function as a
transcriptional cofactor. The aforementioned transactivation
activity harbored within 4ICD may directly cooperate with
STAT5A in the selection and transactivation of target genes. In
addition, ERBB4 may indirectly modulate STAT5A transacti-
vation through nuclear translocation of 4ICD associated tran-
scriptional coactivators. For example, the yes-associated protein
(YAP) transcription factor and its isoforms and independently
expressed 4ICD colocalize within nuclei of cotransfected cells.
Furthermore, a direct association between YAP and 4ICD is es-
sential for ERBB4 transactivation activity in a GAL4 assay
(Komuro et al., 2003). Together, these observations raise the in-
triguing possibility of STAT5A DNA-binding localizing 4ICD
to specific target genes with subsequent 4ICD modulation of
target gene selection or transactivation or both.
Although several transmembrane receptors have been de-
tected in the nucleus, the functional significance of cell surface
receptor nuclear translocation remains an intriguing biologi-
cal problem. Our current results indicate that ERBB4 and
STAT5A use a novel cooperative mechanism of gene reg-
ulation with 4ICD functioning as a nuclear chaperone for
STAT5A and STAT5A mediating nuclear retention of colocal-
ized 4ICD associated at STAT5A target promoters. Both
ERBB4 and STAT5A localize to the nuclei of breast epithe-
lium while supplying essential functions during breast develop-
ment and lactational milk-gene expression (Jones et al., 2003;
Long et al., 2003; Tidcombe et al., 2003), providing a physio-
logically important basis for our current observations. In con-
clusion, we offer a functional explanation for nuclear transloca-
Figure 7. A model for ERBB4 regulation of STAT5A-stimulated gene
expression. Growth factor–stimulated ERBB4 undergoes sequential pro-
teolytic processing at the cell membrane by TACE and presenilin-dependent
 -secretase to release 4ICD. 4ICD accumulates in the perinuclear region
where a perinuclear/nuclear equilibrium is established favoring perinu-
clear over nuclear 4ICD. Cytosolic STAT5A associates with activated
ERBB4/4ICD in an SH2 domain–dependent manner and STAT5A is phos-
phorylated at multiple residues including the regulatory Y694 (Jones et al.,
1999, 2003). Nuclear cotranslocation of 4ICD and STAT5A requires an
intact ERBB4 NLS. The two nuclear proteins bind to STAT5A target promot-
ers containing GAS thereby stimulating expression of STAT5A regulated
milk-genes including  -casein and whey acidic protein (Long et al., 2003).
STAT5A mediates nuclear retention of 4ICD resulting in a dramatic shift
from perinuclear and nuclear accumulation of 4ICD. Interestingly, 4ICD
harbors transactivation activity (TA) which may directly augment STAT5A
target gene expression. 
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tion of transmembrane receptors and describe a unique signal
transduction paradigm that may have important implications
during developmental regulation of gene expression.
 
Materials and methods
 
ERBB4 cDNA
 
The human ERBB4 cDNA used in these experiments has been sequenced
in its entirety (Plowman et al., 1993) and represents the JM-a isoform (Ele-
nius et al., 1997). This isoform retains both TACE and 
 
 
 
-secretase recogni-
tion sequences and is therefore an ERBB4 isoform that undergoes com-
plete proteolytic processing at the cell surface after ligand stimulation.
 
Plasmid constructs
 
The three putative ERBB4 NLS sequences (Srinivasan et al., 2000) and mu-
tations of NLS1 each including a 5
 
 
 
 EcoR1 overhang, Kozak sequence,
start ATG, and 3
 
 
 
 BamH1 site were independently fused to the amino ter-
minus of EGFP by ligating EcoRI–BamHI digested pEGFP-N1 (CLONTECH
Laboratories, Inc.) with the annealed oligonucleotides described in Table I.
The plasmid pERBB4-EGFP expressing full-length human ERBB4
with a carboxyl-terminal EGFP fusion was constructed in three steps. First,
the intermediate construct pcDNA ERBB4 was generated by trimolecular
ligation joining EcoRV–NotI digested pcDNA5/TO (Invitrogen), the 3.8-
kb SalI (site filled with T4 DNA polymerase)–BamHI fragment from
pLXSN-ERBB4 (Riese et al., 1995), and the 315-bp BamHI–NotI digested
PCR product generated from pLXSN-ERBB4 using the forward primer up-
stream of the unique BamHI site 5
 
 
 
-ATGCCAGAGAAGGCCAAG (nt
3705–3723; Plowman et al., 1990) and the reverse primer harboring a
unique EcoRV site, tandem Flag epitope tags, and NotI site downstream
of an amber stop codon 5
 
 
 
-ATAAGAATGCGGCCGCCTACTTGTC-
ATCGTCGTCCTTGTAGTCCTTGTCATCGTCGTCCTTGTAGTCGATATCC-
ACCACAGTATTCCGGTG (nt 3949–3931; Plowman et al., 1990). Next,
the ERBB4 ORF with tandem carboxyl-terminal Flag epitope tags was sub-
cloned into pBluescript SK I (Stratagene) by ligating AflI (site filled with T4
DNA polymerase)–NotI-digested pcDNA-ERBB4 with ClaI (site filled with
T4 DNA polymerase)–NotI-digested pBluescript SK I, generating the plas-
mid pBl-ERBB4. Finally, pERBB4-EGFP was generated by ligating the 4.1-kb
fragment lacking Flag epitope tags from SalI–EcoRV digested pBl-ERBB4
with XmaI (site filled with T4 DNA polymerase)–SalI digested pEGFPN3
(CLONTECH Laboratories, Inc.).
The ERBB4 NLS1 was altered in pERBB4-EGFP through residue sub-
stitutions at K681E, K682I, K683M, R684G to generate the plasmid
pERBB4muNLS-EGFP in multiple steps. The 2.3-kb fragment from SpeI–BclI
digested pBl-ERBB4 harboring NLS1 was subcloned into the same sites of
pBluescript SK I to generate pBl-ERBB4 S/B. NLS1 was mutagenized in
pBl-ERBB4 S/B to generate the clone pBl-ERBB4muNLS by PCR-mediated
site-directed mutagenesis using a downstream primer corresponding to
the T7 promoter, an upstream primer corresponding to the T3 promoter,
and the mutation incorporating oligonucleotide primer pair 5
 
 
 
-AGCATC-
GAAATGATAAGGGCCTTGAGAAGATTCTTGGAA (nt 2085–2106;
Plowman et al., 1990) and 5
 
 
 
-CAAGGCCCTTATCATTTCGATGCTCTTC-
CTTCTAACATA (nt 2091–2053; Plowman et al., 1990). NLS1 mutagenic
primers were designed to generate a novel EcoO109I site. The intermedi-
ate plasmid pERBB4muNLS-EGFP-Int was generated by ligating the 2.3-kb
SpeI–BclI fragment from pBl-ERBB4muNLS and the 4.5-kb SpeI–BclI frag-
ment from pERBB4-EGFP. The final pERBB4muNLS-EGFP construct was
generated by ligating the 1.9-kb SpeI fragment from pERBB4-EGFP into
SpeI digested pERBB4muNLS-EGFP-Int.
The constructs pERBB4-Flag and pERBB4muNLS-Flag were gener-
ated by replacing the 1.8-kb AclI–NotI fragments from pERBB4-EGFP and
pERBB4muNLS-EGFP, respectively, with the corresponding AclI–NotI frag-
ment from pBl-ERBB4.
The construct pRed-STAT5A was generated by tri-molecular ligation
of the HindIII–NruI digested PCR product from amplified pEF-STAT5A
(Jones et al., 1999) using the upstream primer 5
 
 
 
-ATCCCAAGCTTCCAC-
CATGGCGGGCTGGATT supplying a Kozak start site and unique HindIII
site and the primer 5
 
 
 
-ATCTGAAGGTGCTTCTGGGA positioned down
stream of the unique NruI site, the 
 
 2.0-kb pEF-STAT5A NruI–EcoRI frag-
ment, and HindIII–EcoRI digested pdsRed1-C1 (CLONTECH Laboratories,
Inc.). The construct pRed-STAT5AY694F was generated by replacing the
 2.0-kb NruI–EcoRI fragment from pRed-STAT5A with the same frag-
ment  from pEF-STAT5AY694F (Jones et al., 1999). The construct pEF-
STAT5AR618V has been described elsewhere (Jones et al., 1999).
Cell lines and transfections
The human embryonic kidney cell line HEK 293T, NIH 3T3, and COS-7
cell lines were obtained from ATCC and cultured in DMEM with 10% FBS
and 2 mM L-glutamine. The dramatic growth inhibitory effect of ectopic
ERBB4 expression (Sartor et al., 2001) precluded analysis of ERBB4 nu-
clear localization in many common mammalian cell lines. Therefore, we
performed all functional assays in the MCF-7 human breast cancer cell
line MCF-7B, which was modified to stably overexpress BCL-2 (Burow et
al., 2001). MCF-7B cells were cultured in MEM containing 10% FBS, 1
mM Na-pyruvate, and 2 mM L-glutamine.
Transfections were performed on 2  10
5 cells in 35-mm tissue cul-
ture dishes or 0.8   10
5 cells in a two-chamber tissue culture treated glass
slide with 1  g of each transfected DNA using Fugene6 transfection re-
agent (Roche) as described by the manufacturer. In each experiment trans-
fected cells were harvested at 48 h after transfection.
NIH 3T3 cell lines stably expressing ERBB4-Flag (NIH-H4) or
ERBB4muNLS (NIH-H4muNLS) were generated by cotransfecting NIH
3T3 in 35-mm tissue culture dishes at 70% confluence with 0.2  g of
pLXSN and 2  g of pERBB4-Flag or pERBB4muNLS-Flag using Fugene6
as described above. At 2 d after transfection cells were selected by trans-
ferring the contents of a 35-mm dish to a 100-mm tissue culture dish con-
taining selection media (growth media with 2 mg/ml of G418 [Roche]).
After 5 d of selection, resistant colonies were pooled and maintained in
selection media for an additional 2 wk. Successful stable expression of
ERBB4-Flag and ERBB4muNLS-Flag was confirmed by Flag Western blot
analysis of cell lysates.
Western blot analysis
Immunoprecipitations from transfected cell lysates or total cell lysates were
separated on a 7.5% polyacrylamide gel, transferred to Hybond ECL (Am-
ersham Biosciences) membrane, and analyzed by Western blot as de-
scribed previously (Jones et al., 1999). Primary antibodies were anti-ERBB4
(Santa Cruz Biotechnology, Inc.), anti-STAT5A (Santa Cruz Biotechnology,
Inc.), anti-P-Stat5 (Zymed Laboratories), anti–Flag-M2 (Sigma-Aldrich),
and anti–phospho-tyrosine (Santa Cruz Biotechnology, Inc.).
Preparation of membrane and cytosolic cellular fractions
Membrane and cytosolic fractions were isolated from COS-7 cells trans-
fected with vector control, ERBB4-Flag, or ERBB4muNLS-Flag using a mod-
ification of a protocol published elsewhere (Lee et al., 2002). In brief, at
Table I. ERBB4 DNA sequences fused to EGFP
Construct Human ERBB4 sequence ERBB4 residues Altered residues
EGFPN1 NA NA NA
NLS1-EGFP AGAAGGAAGAGCATCAAAAAGAAAAGAGCCTTGAGAAGA R676-R688 NA
NLS2-EGFP CCTTTTGTTTCTCGGAGAAAA P1170-K1176 NA
NLS3-EGFP CCAGAGAAGGCCAAGAAAGCG P1230-A1236 NA
muNLS1-EGFP (676-678) ATAATGGAGAGCATCAAAAAGAAAAGAGCCTTGAGAAGA R676-R688 R676I, R677M,
K678E
muNLS1-EGFP (681-682) AGAAGGAAGAGCATCGAAATAAAAAGAGCCTTGAGAAGA R676-R688 K681E, K682I
muNLS1-EGFP (681-684) AGAAGGAAGAGCATCGAAATAATGGGAGCCTTGAGAAGA R676-R688 K681E, K682I, 
K683M, R684G
muNLS1-EGFP (687-688) AGAAGGAAGAGCATCAAAAAGAAAAGAGCCTTGGGAATA R676-R688 R687G, R6881ERBB4 IS A NUCLEAR CHAPERONE FOR STAT5A • WILLIAMS ET AL. 477
2 d after transfection cells were mock treated or treated with 100 ng/ml of
tetradecanoylphorbol-13-acetate (Sigma-Aldrich) for 30 min at 37 C.
Cells were collected using a rubber policeman, washed twice with ice-
cold PBS, and disrupted with 30 strokes of a dounce homogenizer (pestle
B) in buffer HA (10 mM Tris, pH 7.4, 150 mM NaCl, 5 mM EDTA, 1 mM
PMSF, 1 mM Na3VO4, 1 mM NaF, complete protease inhibitor cocktail
[Roche], phosphatase inhibitor cocktail II [Sigma-Aldrich]). Cell lysates
were centrifuged at 1,500 g for 10 min to remove nuclei and intact cells.
The lysates were incubated at 37 C for 30 min to augment release of
4ICD into the soluble fraction and centrifuged at 200,000 g for 30 min at
4 C to separate membrane and cytosolic fractions. The membrane pellets
were resuspended in buffer HA containing 0.5% NP-40 (Roche). Cytosolic
and membrane fractions (50  g each) were subjected to immunoprecipi-
tation and Western blot analysis.
Deconvolution microscopy
Cells in two-chamber slides transfected with EGFP and dsRed fusion con-
structs were fixed in 4% PFA for 10 min and briefly washed in PBS before
coverslipping in Vectashield with DAPI (Vector Laboratories). Similarly
transfected and fixed MCF-7B cells were counterstained in 500 mM DAPI
(Molecular Probes) and coverslipped with Prolong Antifade Media (Molec-
ular Probes). The slides were analyzed on a DMRXA automated upright
epifluorescent microscope (Leica) equipped with a 63X (NA   1.4) oil-
immersion objective; a Sensicam QE CCD digital camera (Cooke Corpo-
ration); and filter sets optimized for EGFP (exciter HQ480/20, dichroic
Q495LP, and emitter HQ510/20m), RFP (exciter 545/30 , dichroic
Q570DLP, and emitter HQ620/60m), and DAPI (exciter 360/40 ,
dichroic 400DCLP, and emitter GG420LP). Z-axis plane capture, decon-
volution, and analysis were performed with Slidebook Deconvolution Soft-
ware (Intelligent Imaging Innovations).
Analysis involved the creation of an objective, digital binary over-
lay (mask) over arbitrary areas within regions of interest from both green
and red fluorescence channels of all 3D stacks of captured planes (total of
15 per cell at 0.2  m each) from cells demonstrating EGFP-labeled ERBB4
and RFP-labeled STAT5A. Slidebook-driven above-threshold masks were
applied to 10 cells per group, fluorescence channel, and cell region to
isolate both EGFP and RFP expression and discriminate or compare both
EGFP and RFP cytoplasmic and nuclear expression. Analysis also entailed
a pixel correlation algorithm as a measure of colocalization (or lack
thereof) between the EGFP and RFP positive areas within each image (or
plane) by thresholding and channel segmentation through masks. This sta-
tistical measurement determines the degree in which two voxels in a 3D
stack of images correspond to one another and/or establish a spatial lo-
calization trend. If the voxels in both green and red channels arrange in
an overlapping manner or colocalize entirely, then they have a correlation
measurement of 1.0, and are said to be completely correlated. If the two
sets of voxels correspond to each other in the exactly opposite manner,
then they have a correlation measurement of  1.0, and are said to be
negatively correlated. Masks were created based on pixels above thresh-
old for each stack on a per channel and location basis. Thus, a mask was
created for nuclear localization by using the DAPI channel as a template
for the nucleus. A second mask was created based on green voxels in the
intracellular region (including background voxels) to mask the entire cellu-
lar volume. Subsequently, the nuclear mask was subtracted from the intra-
cellular mask to selectively create a template for intracellular expression
with exclusion of nuclear volume. Both EGFP and RFP channels could then
be specifically masked through those templates to identify and localize
their respective voxels to those areas. A digital, background subtraction
then followed. Thresholding and channel segmentation through masks
were also used to measure the mean ERBB4-EGFP intensity in individual
cells throughout their 3D multi-plane digital rendering. The seventh plane
from a z-axis stack deconvolved through a “Nearest Neighbors” algorithm
was extracted for representative and qualitative purposes only.
Extraction of nuclear and membrane/cytosolic proteins
Nuclear and membrane/cytosolic proteins were extracted using a modi-
fied version of celLytic/nuClear (Sigma-Aldrich). In brief, at 2 d after trans-
fection MCF-7B cells in 100-mm tissue culture dishes were mock stimulated
or treated with 50 ng/ml of HRG in PBS for 30 min at RT. Treated cells
were washed with ice-cold PBS, collected into 5 ml of PBS by scraping,
and pelleted by centrifugation. The resultant pellets were resuspended into
150  l of hypotonic lysis buffer (10 mM Hepes, pH 7.9, 1.5 mM MgCl2
10 mM KCl) containing complete protease inhibitor cocktail (Roche) and
phosphatase inhibitor cocktail II (Sigma-Aldrich) and incubated on ice for
15 min. 6  l of 10% IGEPAL CA630 was added, samples were vortexed
for 10 s and then centrifuged for 30 s at 4 C in an Eppendorf centrifuge.
The resultant supernatant representing the membrane/cytosolic fraction
was recovered and stored at  70 C until use. The nuclear pellet was
washed in 1.0 ml of cold PBS, resuspended into 70  l of extraction buffer
(20 mM Hepes, pH 7.9, 1.5 mM MgCl2, 420 mM NaCl2, 0.2 mM EDTA,
25% glycerol) containing protease and phosphatase inhibitors, and vor-
texed for 30 min at 4 C. Samples were centrifuged for 15 min at 4 C in
an eppendorf centrifuge. The resultant nuclear extracts were quick frozen
in liquid nitrogen, and stored at  70 C until use. For Western blot analy-
sis 25  l of each membrane/cytosolic and nuclear extract was separated
on a 7.5% polyacrylamide gel and transferred to Hybond ECL membrane.
Immunofluorescence
NIH 3T3 derived cell lines modified to express ERBB4-Flag (NIH-H4)
or ERBB4muNLS-Flag (NIH-H4muNLS) were plated on glass coverslips
coated with Cell-Tak (BD Biosciences). The cells were allowed to adhere
for 18 h. The cell lines were mock stimulated or stimulated with 50 ng/ml
of HRG for 30 min at RT, fixed with 4% formaldehyde in PBS for 15 min
at RT, and the coverslips were washed three times for 5 min each wash in
ice-cold PBS. Cells were permeabilized by incubating in blocking buffer
(5% goat serum and 0.2% Tween 20 in PBS) for 30 min. Coverslips were
incubated with 1:1,000 dilution of anti-Flag M2 (Sigma-Aldrich) in block-
ing buffer for 90 min. Coverslips were washed three times as above, and
incubated for 30 min with a 1:1,000 dilution of Alexafluor 488–conju-
gated goat anti–mouse IgG (Molecular Probes) in blocking buffer. After
three washes, cells were counterstained in 10 mM Hoechst solution in PBS
for 15 min. Coverslips were washed twice and mounted with Prolong
gold (Molecular Probes).
Luciferase assay
Transfections were performed on MCF-7B cells as described above with
combinations of ERBB4 and STAT5A expression plasmids and a  -casein
promoter luciferase reporter plasmid (provided by L. Hennighausen, Na-
tional Institutes of Health, Bethesda, MD). Cell lysates were prepared at
2 d after transfection in 500  l of cell culture lysis reagent (Promega) and
luciferase assay was performed on 30  l of lysate using the luciferase as-
say system (Promega) in a Berthold AutoLumat Plus luminometer. Each
sample was performed in duplicate and the data represent the mean of at
least three independent experiments. Statistically significant differences
between datasets were determined using the paired t test.
ChIP assay
Association of ERBB4 and STAT5A at the endogenous  -casein promoter
was determined using a modification of the ChIP assay described else-
where (Barre et al., 2003). T47D breast cancer cells which express detect-
able levels of both ERBB4 and STAT5A were grown to 80% confluency on
two 150 mm tissue culture dishes for each experimental treatment ( 5  
10
7 cells). The cells were serum starved overnight by changing the growth
media to media containing 0.2% FBS and then mock stimulated with PBS
or stimulated for 30 min with 5  g/ml of ovine Prl (Sigma-Aldrich) or 50
ng/ml of HRG. Cells were washed with PBS then cross-linked with 1% PFA
in PBS for 10 min at RT. The fixed cells were removed with a cell scraper,
washed twice in PBS, resuspended into 2.0 ml of lysis buffer (50 mM Tris,
pH 8.0, 10 mM EDTA, 1% SDS, 1 mM PMSF, complete protease inhibitor
[Roche], phosphatase inhibitor cocktail II [Sigma-Aldrich]), and sonicated
three times for 15 s using a small probe in a Fisher Sonic Dismembrator
model 300 set at 35%. Cellular debris was removed by centrifugation at
12,000 rpm for 10 min at 4 C and the lysate was brought up to a final
volume of 5.0 ml with dilution buffer (20 mM Tris, pH 8.0, 2 mM EDTA,
150 mM NaCl, 1% NP-40 [Roche], 1 mM PMSF, complete protease inhib-
itor, phosphatase inhibitor cocktail II). The lysate was precleared by incu-
bating for 2 h at 4 C with 100  l of protein A Sepharose (Amersham Bio-
sciences), 10  g/ml of salmon sperm DNA, and 10  g of rabbit IgG
(Santa Cruz Biotechnology, Inc.). Input chromatin was prepared from 500
 l of precleared lysate and processed along with the immunoprecipita-
tions at the cross-link reversal step. Immunoprecipitations were performed
overnight at 4 C on 1.0 ml of precleared lysate with 2  g of rabbit anti-
ERBB4 C-18 (Santa Cruz Biotechnology, Inc.) or rabbit anti-STAT5A L-20
(Santa Cruz Biotechnology, Inc.). Immune complexes were removed by
adding 40  l of a 50% protein A Sepharose slurry for 1 h at 4 C. The
immunoprecipitates were washed twice for 10 min each with TSE I (20
mM Tris, pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM
PMSF, complete protease inhibitor), TSE II (20 mM Tris, pH 8.0, 2 mM
EDTA, 500 mM NaCl, 1% NP-40, 0.1% SDS, 1 mM PMSF, complete pro-
tease inhibitor), buffer III (10 mM Tris, pH 8.0, 1 mM EDTA, 250 mM LiCl,
1% NP-40, 1% deoxycholate, 1 mM PMSF, complete protease inhibitor),
and finally three washes with TE buffer. Bound complexes were elutedJCB • VOLUME 167 • NUMBER 3 • 2004 478
three times for 10 min with 200  l of 1% SDS, 100 mM NaHCO3 and for-
malin cross-links were reversed by incubating the eluates at 65 C over-
night. The samples were digested by adding 80  g of proteinase K for 1 h
at 55 C, extracted once with phenol/chloroform/isoamyl alcohol, and nu-
cleic acids were precipitated with 10  g of t-RNA (Sigma-Aldrich) carrier
using standard techniques. The dried nucleic acid pellet was resuspended
into 50  l of ddH2O and 5  l was used for each 35 cycle PCR. The input
controls were used at a dilution of 1/100. The PCR primers 5 -GATGAG-
CATTACAAGGATATG and 5 -TAAGCTGAGTATAGACCTAC were de-
signed to amplify a region of the  -casein promoter containing three po-
tential distal STAT5A binding sites ( 4719 to  4276; Winklehner-
Jennewein et al., 1998) and the PCR primers 5 -ACTGTCCTCCAGTCAT-
TGTCT and 5 -TGGTCCATCAGCTTCTGTGAC were designed to amplify
a region of the  -casein promoter containing a proximal STAT5A binding
site ( 249 to  1; Winklehner-Jennewein et al., 1998). As a negative con-
trol the PCR primers 5 -GACAGATCTGAGTCCAACTGG and 5 -
GGAATCTGGGTGGCTTGTATAGG were designed to amplify a region of
the   -casein promoter lacking STAT5A binding sites ( 923 to  590;
Winklehner-Jennewein et al., 1998).
Online supplemental material
Fig. S1 shows that the ERBB4-EGFP and dsRed-STAT5A fusion proteins re-
tain normal signaling activities. Fig. S2 demonstrates that ERBB4muNLS,
harboring mutational inactivation of ERBB4 NLS1 (K681E, K682I,
K683M, R684G), undergoes normal growth factor-stimulated activation
and proteolytic processing to release the 4ICD. Fig. S3 shows that
ERBB4muNLS stably expressed in NIH 3T3 cells fails to translocate to the
nucleus after HRG stimulation. Online supplemental material is available
at http://www.jcb.org/cgi/content/full/jcb.200403155/DC1.
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